UBS Downgrades AstraZeneca (AZN) to Neutral

November 4, 2013 8:32 AM

UBS downgraded AstraZeneca (NYSE: AZN) from Buy to Neutral.

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found